Lab
Shawnee Mission Medical Center INC
Shawnee Mission Medical Center INC was paid $24K by Medicaid between Jan 2020 and Dec 2022, across 20 billing codes. Its largest line is 80061, Lipid panel — 20% of everything it billed.
33Billing provider infoSHAWNEE MISSION MEDICAL CENTER INC
MERRIAM, KS 66204
MERRIAM, KS 66204
33aNPI1235792003assigned 04/17/2019
33bProvider typeClinical Medical Laboratory
28Total paid$24K
24GClaims6,677
24DCodes billed20
24AFirst – last monthJan 2020 – Dec 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Kansas
Rank by total paid#27 of 47
Median peer was paid$64K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 400 | $1K | |
| 2021 | 2,371 | $8K | |
| 2022 | 3,906 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80061 | Lipid panel | 20% | 715 | 686 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | 17% | 544 | 527 | $4K |
| 80053 | Comprehensive metabolic panel | 14% | 697 | 660 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 11% | 538 | 522 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.7% | 49 | 48 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.5% | 187 | 179 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.8% | 581 | 552 | $1K |
| 84439 | 4.2% | 196 | 193 | $1K | |
| 82607 | 3.4% | 136 | 132 | $815.60 | |
| 82728 | 1.5% | 60 | 60 | $348.43 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 12 | 12 | $341.19 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 12 | 12 | $341.19 |
8 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $201.72 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,243 | $190.48 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 43 | $185.13 |
| 80050 | General health panel | <1% | 511 | $178.50 |
| 82570 | <1% | 40 | $106.77 | |
| 83540 | <1% | 45 | $100.18 | |
| 82043 | <1% | 40 | $97.16 | |
| 84466 | <1% | 16 | $64.69 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOTHIN OWEN, MAIRILISE (CFO)